Sign in
8-K

Current Report

Aclaris Therapeutics, Inc. Filed Acc 0001558370-23-019911

Exit or restructuring costs · Regulation FD disclosure

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading acrs-20231219x8k.htm…